Whitebox Advisors’s European Biotech Acquisition Corp. Warrant EBACW Stock Holding History

Whitebox Advisors’s Portfolio EBACW Stock Details EBACW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-16,833	Closed	-$5.02K	–	733
2022 Q4	$5.02K	Hold	16,833	–	–	﹤0.01%	555
2022 Q3	$2K	Hold	16,833	–	–	﹤0.01%	869
2022 Q2	$3K	Hold	16,833	–	–	﹤0.01%	841
2022 Q1	$3K	Hold	16,833	–	–	﹤0.01%	939
2021 Q4	$10K	Buy	+16,833	New	+$10.8K	﹤0.01%	806

Whitebox Advisors's EBACW Position: Q1 2023 in Review

Whitebox Advisors sold out of European Biotech Acquisition Corp. Warrant (EBACW) in Q1 2023, closing a stake of 16,833 shares — an estimated $5.02K sold.

Whitebox Advisors first reported a position in EBACW in Q4 2021 and held it in 5 quarters. The position peaked at $10K in Q4 2021. 0 funds tracked by Wall St. Rank hold EBACW as of Q1 2023.

Whitebox Advisors reported no remaining European Biotech Acquisition Corp. Warrant position as of Q1 2023 after selling out during the quarter.
Whitebox Advisors sold 16,833 European Biotech Acquisition Corp. Warrant shares in Q1 2023, an estimated $5.02K.
Whitebox Advisors first reported a position in European Biotech Acquisition Corp. Warrant in Q4 2021 and held it in 5 quarters.
Whitebox Advisors's European Biotech Acquisition Corp. Warrant position peaked at $10K in Q4 2021.
0 funds tracked by Wall St. Rank held European Biotech Acquisition Corp. Warrant as of Q1 2023.

Based on Whitebox Advisors's 13F filing for Q1 2023, filed 15 May 2023.